Explore All Access
Check if your research matches the topics covered in CNS Drugs?
- Degree of match
- Common matching concepts
- Additional journal recommendations
CNS Drugs : Impact Factor & More
eISSN: 1179-1934pISSN: 1172-7047
Share this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
CNS Drugs Key Metrics
CiteScore 
9.8
SNIP
1.87
CNS Drugs Journal Specifications
| Overview | |
| Publisher | ADIS INT LTD |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1994 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in CNS Drugs ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in CNS Drugs
Randomized, Double-Blind, Placebo-Controlled Trial on the Efficacy, Safety and Tolerability of Modified-Release Methylphenidate (MPH-MR) in Chinese Children and Adolescents with Attention-Deficit/Hyperactivity Disorder (ADHD).
- 13 Dec 2024
- CNS drugs
The Role of GABA Receptors in Anesthesia and Sedation: An Updated Review.
- 27 Oct 2024
- CNS drugs
A Multicenter, Open-Label Study to Evaluate the Long-term Safety and Efficacy of Adjunctive Brexpiprazole 2 mg Daily in Japanese Patients with Major Depressive Disorder.
- 18 Oct 2024
- CNS drugs
The Safety of Alcohol Pharmacotherapies in Pregnancy: A Scoping Review of Human and Animal Research.
- 10 Oct 2024
- CNS drugs
Efficacy of Cariprazine in the Psychosis Spectrum: A Systematic Review and Network Meta-Analysis of Randomised Controlled Trials in Schizophrenia and Bipolar Disorder.
- 9 Oct 2024
- CNS drugs
Current Perspectives on the Clinical Research and Medicalization of Psychedelic Drugs for Addiction Treatments: Safety, Efficacy, Limitations and Challenges.
- 1 Oct 2024
- CNS drugs
Randomized, Double-Blind, Placebo-Controlled Trial on the Efficacy, Safety and Tolerability of Modified-Release Methylphenidate (MPH-MR) in Chinese Children and Adolescents with Attention-Deficit/Hyperactivity Disorder (ADHD).
- 13 Dec 2024
- CNS drugs
The Role of GABA Receptors in Anesthesia and Sedation: An Updated Review.
- 27 Oct 2024
- CNS drugs
A Multicenter, Open-Label Study to Evaluate the Long-term Safety and Efficacy of Adjunctive Brexpiprazole 2 mg Daily in Japanese Patients with Major Depressive Disorder.
- 18 Oct 2024
- CNS drugs
The Safety of Alcohol Pharmacotherapies in Pregnancy: A Scoping Review of Human and Animal Research.
- 10 Oct 2024
- CNS drugs
Efficacy of Cariprazine in the Psychosis Spectrum: A Systematic Review and Network Meta-Analysis of Randomised Controlled Trials in Schizophrenia and Bipolar Disorder.
- 9 Oct 2024
- CNS drugs
Current Perspectives on the Clinical Research and Medicalization of Psychedelic Drugs for Addiction Treatments: Safety, Efficacy, Limitations and Challenges.
- 1 Oct 2024
- CNS drugs
FAQs on CNS Drugs
How long has CNS Drugs been actively publishing? 
CNS Drugs has been in operation since 1994 till date.
What is the publishing frequency of CNS Drugs?
CNS Drugs published with a Monthly frequency.
How many articles did CNS Drugs publish last year?
In 2024, CNS Drugs publsihed 24 articles.
What is the eISSN & pISSN for CNS Drugs?
For CNS Drugs, eISSN is 1179-1934 and pISSN is 1172-7047.
What is Citescore for CNS Drugs?
Citescore for CNS Drugs is 9.8.
What is SNIP score for CNS Drugs?
SNIP score for CNS Drugs is 1.87.
Who is the publisher of CNS Drugs?
ADIS INT LTD is the publisher of CNS Drugs.
